sevoflurane has been researched along with Liver Neoplasms in 12 studies
Sevoflurane: A non-explosive inhalation anesthetic used in the induction and maintenance of general anesthesia. It does not cause respiratory irritation and may also prevent PLATELET AGGREGATION.
sevoflurane : An ether compound having fluoromethyl and 1,1,1,3,3,3-hexafluoroisopropyl as the two alkyl groups.
Liver Neoplasms: Tumors or cancer of the LIVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Remifentanil is widely used for ultrasound-guided percutaneous radiofrequency ablation (RFA) of small hepatocellular carcinoma (HCC)." | 9.30 | Comparison of dexmedetomidine vs. remifentanil combined with sevoflurane during radiofrequency ablation of hepatocellular carcinoma: a randomized controlled trial. ( Chen, HX; He, Y; Hei, Z; Jian, C; Li, X; Pan, J; Zhou, S, 2019) |
| "Hepatocellular carcinoma (HCC) cells were treated with sevoflurane for 12 or 24 h." | 8.31 | Sevoflurane suppresses hepatocellular carcinoma cell progression via circ_0001649/miR-19a-3p/SGTB axis. ( Gong, J; Liu, J; Sun, N; Yang, X; Zhang, W, 2023) |
| "We investigated the effects of sevoflurane exposure on the expression of matrix metalloproteinase (MMP), expression and ablation of natural killer group 2, member D (NKG2D) ligands (UL16-binding proteins 1-3 and major histocompatibility complex class I chain-related molecules A/B), and natural killer (NK) cell-mediated cytotoxicity in breast cancer cells." | 8.31 | Effects of sevoflurane on metalloproteinase and natural killer group 2, member D (NKG2D) ligand expression and natural killer cell-mediated cytotoxicity in breast cancer: an in vitro study. ( Bae, J; Hong, JM; Jeon, S; Kim, HJ; Kim, JR; Kwon, SK; Lee, HJ; Paek, SI; Park, S; Ri, HS; Yun, EJ, 2023) |
| "Sevoflurane (SEVO) inactivates the aggressiveness of hepatocellular carcinoma (HCC) cells by mediating microRNAs (miRNAs)." | 8.02 | microRNA-148a-3p enhances the effects of sevoflurane on hepatocellular carcinoma cell progression via ROCK1 repression. ( Liu, L; Sun, H; Sun, Y; Xing, W, 2021) |
| "Sevoflurane (SEVO) is widely applied as an anesthetic, which exerts antitumor capacity in various cancers, including hepatocellular carcinoma (HCC)." | 8.02 | lncRNA KCNQ1OT1 reverses the effect of sevoflurane on hepatocellular carcinoma progression via regulating the miR-29a-3p/CBX3 axis. ( Li, H; Liu, F; Shang, S; Zhou, W, 2021) |
| "Compared with sevoflurane anesthesia, propofol may improve postoperative Aβ-42 and Tau protein levels in patients with hepatocellular carcinoma, and ameliorate postoperative cognitive function." | 7.91 | Effect of propofol and sevoflurane anesthesia on postoperative cognitive function and levels of Aβ-42 and Tau in patients undergoing hepatectomy. ( Hou, JF; Xiao, CL, 2019) |
| "Remifentanil is widely used for ultrasound-guided percutaneous radiofrequency ablation (RFA) of small hepatocellular carcinoma (HCC)." | 5.30 | Comparison of dexmedetomidine vs. remifentanil combined with sevoflurane during radiofrequency ablation of hepatocellular carcinoma: a randomized controlled trial. ( Chen, HX; He, Y; Hei, Z; Jian, C; Li, X; Pan, J; Zhou, S, 2019) |
| "Hepatocellular carcinoma (HCC) cells were treated with sevoflurane for 12 or 24 h." | 4.31 | Sevoflurane suppresses hepatocellular carcinoma cell progression via circ_0001649/miR-19a-3p/SGTB axis. ( Gong, J; Liu, J; Sun, N; Yang, X; Zhang, W, 2023) |
| "We investigated the effects of sevoflurane exposure on the expression of matrix metalloproteinase (MMP), expression and ablation of natural killer group 2, member D (NKG2D) ligands (UL16-binding proteins 1-3 and major histocompatibility complex class I chain-related molecules A/B), and natural killer (NK) cell-mediated cytotoxicity in breast cancer cells." | 4.31 | Effects of sevoflurane on metalloproteinase and natural killer group 2, member D (NKG2D) ligand expression and natural killer cell-mediated cytotoxicity in breast cancer: an in vitro study. ( Bae, J; Hong, JM; Jeon, S; Kim, HJ; Kim, JR; Kwon, SK; Lee, HJ; Paek, SI; Park, S; Ri, HS; Yun, EJ, 2023) |
| "Sevoflurane (SEVO) inactivates the aggressiveness of hepatocellular carcinoma (HCC) cells by mediating microRNAs (miRNAs)." | 4.02 | microRNA-148a-3p enhances the effects of sevoflurane on hepatocellular carcinoma cell progression via ROCK1 repression. ( Liu, L; Sun, H; Sun, Y; Xing, W, 2021) |
| "Sevoflurane (SEVO) is widely applied as an anesthetic, which exerts antitumor capacity in various cancers, including hepatocellular carcinoma (HCC)." | 4.02 | lncRNA KCNQ1OT1 reverses the effect of sevoflurane on hepatocellular carcinoma progression via regulating the miR-29a-3p/CBX3 axis. ( Li, H; Liu, F; Shang, S; Zhou, W, 2021) |
| "Compared with sevoflurane anesthesia, propofol may improve postoperative Aβ-42 and Tau protein levels in patients with hepatocellular carcinoma, and ameliorate postoperative cognitive function." | 3.91 | Effect of propofol and sevoflurane anesthesia on postoperative cognitive function and levels of Aβ-42 and Tau in patients undergoing hepatectomy. ( Hou, JF; Xiao, CL, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 6 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, N | 1 |
| Gong, J | 1 |
| Zhang, W | 1 |
| Yang, X | 1 |
| Liu, J | 2 |
| Sun, X | 1 |
| Li, Q | 1 |
| Yang, L | 1 |
| Kim, HJ | 1 |
| Jeon, S | 1 |
| Lee, HJ | 1 |
| Bae, J | 1 |
| Ri, HS | 1 |
| Hong, JM | 1 |
| Paek, SI | 1 |
| Kwon, SK | 1 |
| Kim, JR | 1 |
| Park, S | 1 |
| Yun, EJ | 1 |
| Cao, Y | 1 |
| Lv, W | 1 |
| Ding, W | 1 |
| Li, J | 1 |
| Sun, Y | 1 |
| Liu, L | 1 |
| Xing, W | 1 |
| Sun, H | 1 |
| Zhou, W | 1 |
| Li, H | 1 |
| Shang, S | 1 |
| Liu, F | 1 |
| Pan, J | 1 |
| Li, X | 1 |
| He, Y | 1 |
| Jian, C | 1 |
| Chen, HX | 1 |
| Hei, Z | 1 |
| Zhou, S | 1 |
| Hou, JF | 1 |
| Xiao, CL | 1 |
| Song, G | 1 |
| Tian, L | 1 |
| Cheng, Y | 1 |
| Wang, K | 1 |
| Li, S | 1 |
| Li, T | 1 |
| Rodríguez, A | 1 |
| Taurà, P | 1 |
| García Domingo, MI | 1 |
| Herrero, E | 1 |
| Camps, J | 1 |
| Forcada, P | 1 |
| Sabaté, S | 1 |
| Cugat, E | 1 |
| Nishiwada, T | 1 |
| Kawaraguchi, Y | 1 |
| Uemura, K | 1 |
| Sugimoto, H | 1 |
| Kawaguchi, M | 1 |
| Beck-Schimmer, B | 1 |
| Breitenstein, S | 1 |
| Urech, S | 1 |
| De Conno, E | 1 |
| Wittlinger, M | 1 |
| Puhan, M | 1 |
| Jochum, W | 1 |
| Spahn, DR | 1 |
| Graf, R | 1 |
| Clavien, PA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Role of Volatile Anesthetics for Hepatic Protection in Ischemia-reperfusion[NCT00516711] | 0 participants | Interventional | 2006-03-31 | Completed | |||
| Pharmacological Preconditioning With Desflurane in Liver Surgery[NCT03848780] | 46 participants (Actual) | Interventional | 2016-04-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for sevoflurane and Liver Neoplasms
| Article | Year |
|---|---|
Comparison of dexmedetomidine vs. remifentanil combined with sevoflurane during radiofrequency ablation of hepatocellular carcinoma: a randomized controlled trial.
Topics: Adult; Aged; Anesthesia, General; Carcinoma, Hepatocellular; Catheter Ablation; Dexmedetomidine; Fem | 2019 |
Hepatic cytoprotective effect of ischemic and anesthetic preconditioning before liver resection when using intermittent vascular inflow occlusion: a randomized clinical trial.
Topics: Adult; Aged; Aged, 80 and over; Anesthetics, Inhalation; Caspase 3; Female; Hepatectomy; Humans; Isc | 2015 |
A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic.
Topics: Adult; Aged; Alanine Transaminase; Anesthetics, Inhalation; Aspartate Aminotransferases; Colorectal | 2008 |
A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic.
Topics: Adult; Aged; Alanine Transaminase; Anesthetics, Inhalation; Aspartate Aminotransferases; Colorectal | 2008 |
A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic.
Topics: Adult; Aged; Alanine Transaminase; Anesthetics, Inhalation; Aspartate Aminotransferases; Colorectal | 2008 |
A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic.
Topics: Adult; Aged; Alanine Transaminase; Anesthetics, Inhalation; Aspartate Aminotransferases; Colorectal | 2008 |
9 other studies available for sevoflurane and Liver Neoplasms
| Article | Year |
|---|---|
Sevoflurane suppresses hepatocellular carcinoma cell progression via circ_0001649/miR-19a-3p/SGTB axis.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Liver Neopla | 2023 |
Sevoflurane Inhibits lncRNA HOTAIR-Modulated Stability of HK2 mRNA in a m6A-Dependent Manner to Dampen Aerobic Glycolysis and Proliferation in Lung Cancer.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Glycolysis; | 2022 |
Effects of sevoflurane on metalloproteinase and natural killer group 2, member D (NKG2D) ligand expression and natural killer cell-mediated cytotoxicity in breast cancer: an in vitro study.
Topics: Breast Neoplasms; Carcinoma, Hepatocellular; Female; Humans; Killer Cells, Natural; Ligands; Liver N | 2023 |
Sevoflurane inhibits the proliferation and invasion of hepatocellular carcinoma cells through regulating the PTEN/Akt/GSK‑3β/β‑catenin signaling pathway by downregulating miR‑25‑3p.
Topics: Apoptosis; beta Catenin; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Glycogen S | 2020 |
microRNA-148a-3p enhances the effects of sevoflurane on hepatocellular carcinoma cell progression via ROCK1 repression.
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Humans; Liver Neoplasms; Micr | 2021 |
lncRNA KCNQ1OT1 reverses the effect of sevoflurane on hepatocellular carcinoma progression via regulating the miR-29a-3p/CBX3 axis.
Topics: Carcinoma, Hepatocellular; Chromosomal Proteins, Non-Histone; Humans; Liver Neoplasms; MicroRNAs; Po | 2021 |
Effect of propofol and sevoflurane anesthesia on postoperative cognitive function and levels of Aβ-42 and Tau in patients undergoing hepatectomy.
Topics: Adult; Amyloid beta-Peptides; Anesthesia; Anesthetics, Inhalation; Anesthetics, Intravenous; Carcino | 2019 |
Antitumor activity of sevoflurane in HCC cell line is mediated by miR-29a-induced suppression of Dnmt3a.
Topics: 3' Untranslated Regions; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line; Cel | 2019 |
Effect of sevoflurane on human hepatocellular carcinoma HepG2 cells under conditions of high glucose and insulin.
Topics: Anesthetics, Inhalation; Carcinoma, Hepatocellular; Cell Proliferation; Glucose; Hep G2 Cells; Human | 2015 |